Structural Heart Occluders Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Structural Heart Occluders Pipeline Market Report Overview
Structural heart occluders are used for the treatment of congenital heart defects by closing openings in the heart. Structural heart occluders cover left atrial appendage closure devices, atrial septal defect occluders, ventricular septal defect occluders, patent foramen ovale closure devices, and patent ductus arteriosus closure devices. The structural heart occluders pipeline market research report provides comprehensive information about the structural heart occluders pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.
Key Segments | · Left Atrial Appendage Closure Devices
· Patent Foramen Ovale Closure Devices · Atrial Septal Defect Occluders · Ventricular Septal Defect Occluders |
Key Territories | · The US
· China · Canada · Japan · Europe |
Key Regulatory Paths | · PMA
· NMPA · Shonin · MDL · CE |
Leading Companies | · Abbott Japan Co Ltd
· Append Medical · Boston Scientific Corp · CARAG AG · Dextera Surgical Inc |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Structural Heart Occluders Pipeline Market by Segments
Some of the key segments in the structural heart occluders pipeline market are Left Atrial Appendage Closure Devices, Patent Foramen Ovale Closure Devices, Atrial Septal Defect Occluders, and Ventricular Septal Defect Occluders. As of November 2023, left atrial appendage closure devices have the highest number of pipeline products.
Structural Heart Occluders Pipeline Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Segment Insights into the Structural Heart Occluders Pipeline Market
Structural Heart Occluders Pipeline Market Segmentation by Territories
Some of the key territories in the structural heart occluders market are the US, China, Canada, Japan, and Europe among others. As of November 2023, the US has the highest number of pipeline products.
Structural Heart Occluders Pipeline Market Analysis by Territories, 2023 (%)
Buy the Full Report for More Territory Insights into the Structural Heart Occluders Pipeline Market
Structural Heart Occluders Pipeline Market Segmentation by Regulatory Paths
Some of the key regulatory paths in the structural heart occluders pipeline market are PMA, NMPA, Shonin, MDL, and CE, among others. As of November 2023, PMA is the most followed pathway for pipeline products in the market.
Structural Heart Occluders Pipeline Market Analysis by Regulatory Paths, 2023 (%)
Buy the Full Report for More Regulatory Path Insights into the Structural Heart Occluders Pipeline Market
Structural Heart Occluders Pipeline Market – Competitive Landscape
Some of the key companies in the structural heart occluders pipeline market are Abbott Japan Co Ltd, Append Medical, Boston Scientific Corp, CARAG AG, and Dextera Surgical Inc. among others.
Abbott Japan Co Ltd: Abbott Japan Co Ltd (Abbott Japan), a subsidiary of Abbott Laboratories is a healthcare company that develops, manufactures, and markets prescription drugs, diagnostic reagents, nutritional supplements, oral nutritional supplements, medical equipment, and diagnostic equipment. The company’s products include ethical drugs, blood sugar measurement-related products, gene-related products, immunoassay testing-related products, hematology testing-related products, and nutritious food products.
Structural Heart Occluders Pipeline Market Analysis by Companies, 2023
Buy the Full Report for More Company Insights into the Structural Heart Occluders Pipeline Market
Download a Free Report Sample
Segments Covered in the Report
Structural Heart Occluders Pipeline Market Segments Outlook
- Left Atrial Appendage Closure Devices
- Patent Foramen Ovale Closure Devices
- Atrial Septal Defect Occluders
- Ventricular Septal Defect Occluders
Structural Heart Occluders Pipeline Market Territories Outlook
- The US
- China
- Canada
- Japan
- Europe
Structural Heart Occluders Pipeline Market Regulatory Paths Outlook
- PMA
- NMPA
- Shonin
- MDL
- CE
Scope
This report provides:
- Extensive coverage of the structural heart occluders under development.
- Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of structural heart occluders and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Provides key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
- Identify and understand important and diverse types of structural heart occluders under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- In-depth analysis of the product’s current stage of development, territory, and estimated launch date.
Aegis Medical Innovations Inc.
Aporo Biomedical, Inc. (Inactive)
Append Medical
atHeart Medical
AuriGen Medical Ltd
Boston Scientific Corp
CARAG AG
Cierra, Inc. (Inactive)
Conformal Medical Inc
Cor Habere Corp
Dextera Surgical Inc
Endomimetics LLC
Ension, Inc.
Guangdong Pulse Medical Technology Co Ltd
Hangzhou Dinova EP Technology Co Ltd
Hansen Medical Inc (Inactive)
Jenscare Scientific Co Ltd
Laminar Inc
Lepu Scientech Medical Technology (Shanghai) Co Ltd
Lifetech Scientific (Shenzhen) Co Ltd
LuSeed Vascular
Mayo Clinic
Medtronic Plc
Micro Interventional Devices, Inc.
Northwestern University
Occlutech International AB
SentreHEART Inc
SeptRx, Inc. (Inactive)
Shanghai Shenqi Medical Technology Co Ltd
Swissimplant AG
The Chaim Sheba Medical Center
University of Minnesota
Vascular Closure Systems Inc
Vascular Concepts Ltd
W. L. Gore & Associates Inc
Worry Free Beating
Table of Contents
Table
Figures
Frequently asked questions
-
Which is the leading segment in the structural heart occluders pipeline market?
Left atrial appendage closure devices are the leading segment in the structural heart occluders pipeline market as of November 2023.
-
Which territory has the highest number of products in the structural heart occluders pipeline market?
As of November 2023, the US has the highest number of products in the structural heart occluders pipeline market.
-
Which is the most followed regulatory pathway in the structural heart occluders pipeline market?
As of November 2023, PMA is the most followed pathway for pipeline products in the structural heart occluders market.
-
Which are the major companies operating in the structural heart occluders pipeline market?
Some of the key companies in the structural heart occluders pipeline market are Abbott Japan Co Ltd, Append Medical, Boston Scientific Corp, CARAG AG, and Dextera Surgical Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.